Scarlata, G.G.M.; Quirino, A.; Costache, C.; Toc, D.A.; Marascio, N.; Pantanella, M.; Leucuta, D.C.; Ismaiel, A.; Dumitrascu, D.L.; Abenavoli, L.
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients. Antibiotics 2024, 13, 769.
https://doi.org/10.3390/antibiotics13080769
AMA Style
Scarlata GGM, Quirino A, Costache C, Toc DA, Marascio N, Pantanella M, Leucuta DC, Ismaiel A, Dumitrascu DL, Abenavoli L.
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients. Antibiotics. 2024; 13(8):769.
https://doi.org/10.3390/antibiotics13080769
Chicago/Turabian Style
Scarlata, Giuseppe Guido Maria, Angela Quirino, Carmen Costache, Dan Alexandru Toc, Nadia Marascio, Marta Pantanella, Daniel Corneliu Leucuta, Abdulrahman Ismaiel, Dan Lucian Dumitrascu, and Ludovico Abenavoli.
2024. "Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients" Antibiotics 13, no. 8: 769.
https://doi.org/10.3390/antibiotics13080769
APA Style
Scarlata, G. G. M., Quirino, A., Costache, C., Toc, D. A., Marascio, N., Pantanella, M., Leucuta, D. C., Ismaiel, A., Dumitrascu, D. L., & Abenavoli, L.
(2024). Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients. Antibiotics, 13(8), 769.
https://doi.org/10.3390/antibiotics13080769
